{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:29:57Z","timestamp":1793942997556,"version":"4.8.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12985-017-0837-y","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T07:41:21Z","timestamp":1504165281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence of human pegivirus-1 and sequence variability of its E2 glycoprotein estimated from screening donors of fetal stem cell-containing material"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5704-6443","authenticated-orcid":false,"given":"Yakov","family":"Vitrenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Kostenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Kulebyakina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khrystyna","family":"Sorochynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,31]]},"reference":[{"key":"837_CR1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nm0695-564","volume":"1","author":"JN Simons","year":"1995","unstructured":"Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med. 1995;1:564\u20139.","journal-title":"Nat Med"},{"key":"837_CR2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(95)91802-7","volume":"346","author":"M Yoshiba","year":"1995","unstructured":"Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet. 1995;346:1131\u20132.","journal-title":"Lancet"},{"key":"837_CR3","doi-asserted-by":"crossref","unstructured":"Stapleton JT, Foung S, Muerhoff AS, Bukh J, Simmonds P. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol. 2011;92(Pt2):233\u201346.","DOI":"10.1099\/vir.0.027490-0"},{"key":"837_CR4","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1099\/jgv.0.000393","volume":"97","author":"DB Smith","year":"2016","unstructured":"Smith DB, Becher P, Bukh J, Gould EA, Meyers G, Monath T, et al. Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family. J. Gen. Virol. 2016;97:2894\u2013907.","journal-title":"J. Gen. Virol."},{"key":"837_CR5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2893.2009.01194.x","volume":"16","author":"EL Mohr","year":"2009","unstructured":"Mohr EL, Stapleton JT. GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepat. 2009;16:757\u201368.","journal-title":"J Viral Hepat"},{"key":"837_CR6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<60::AID-JMV10>3.0.CO;2-A","volume":"48","author":"TP Leary","year":"1996","unstructured":"Leary TP, Muerhoff S, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol. 1996;48:60\u20137.","journal-title":"J Med Virol"},{"key":"837_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1096-9071(199806)55:2<109::AID-JMV5>3.0.CO;2-6","volume":"55","author":"T Kato","year":"1998","unstructured":"Kato T, Mizokami M, Nakano T, Orito E, Ohba KI, Kondo Y, et al. Heterogeneity in E2 region of GBV-C\/hepatitis G virus and hepatitis C virus. J Med Virol. 1998;55:109\u201317.","journal-title":"J Med Virol"},{"issue":"Pt 11","key":"837_CR8","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1099\/0022-1317-78-11-2771","volume":"78","author":"MY Lim","year":"1997","unstructured":"Lim MY, Fry K, Yun A, Chong S, Linnen J, Fung K, et al. Sequence variation and phylogenetic analysis of envelope glycoprotein of hepatitis G virus. J Gen Virol. 1997;78(Pt 11):2771\u20137.","journal-title":"J Gen Virol"},{"key":"837_CR9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1099\/0022-1317-81-3-769","volume":"81","author":"DB Smith","year":"2000","unstructured":"Smith DB, Haydon D, Cuceanu N, Prescott L, Kamenka C, Millband D, et al. Phylogenetic analysis of GBV-C\/hepatitis G virus. J Gen Virol. 2000;81:769\u201380.","journal-title":"J Gen Virol"},{"key":"837_CR10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0168-8278(96)80125-5","volume":"25","author":"AS Muerhoff","year":"1996","unstructured":"Muerhoff AS, Simons JN, Leary TP, Erker JC, Chalmers ML, Pilot-Matias TJ, et al. Sequence heterogeneity within the 5\u2032-terminal region of the hepatitis GB virus C genome and evidence for genotypes. J Hepatol. 1996;25:379\u201384.","journal-title":"J Hepatol"},{"key":"837_CR11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jmv.20510","volume":"78","author":"AS Muerhoff","year":"2006","unstructured":"Muerhoff AS, Dawson GJ, Desai SM. A previously unrecognized sixth genotype of GB virus C revealed by analysis of 5\u2032-untranslated region sequences. J Med Virol. 2006;78:105\u201311.","journal-title":"J Med Virol"},{"key":"837_CR12","doi-asserted-by":"crossref","unstructured":"Feng Y, Zhao W, Feng Y, Dai J, Li Z, Zhang X, et al. A novel genotype of GB virus C: its identification and predominance among injecting drug users in Yunnan, China. Davis T, editor. PLoS One. 2011;6:e21151.","DOI":"10.1371\/journal.pone.0021151"},{"key":"837_CR13","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1086\/517431","volume":"177","author":"S Heringlake","year":"1998","unstructured":"Heringlake S, Ockenga J, Tillmann HL, Trautwein C, Meissner D, Stoll M, et al. GB virus C\/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis. 1998;177:1723\u20136.","journal-title":"J Infect Dis"},{"key":"837_CR14","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1086\/498170","volume":"192","author":"J Xiang","year":"2005","unstructured":"Xiang J, Sathar MA, McLinden JH, Klinzman D, Chang Q, Stapleton JT. South African GB virus C isolates: interactions between genotypes 1 and 5 isolates and HIV. J Infect Dis. 2005;192:2147\u201351.","journal-title":"J Infect Dis"},{"key":"837_CR15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/505713","volume":"194","author":"C Schwarze-Zander","year":"2006","unstructured":"Schwarze-Zander C, Blackard JT, Zheng H, Addo MM, Lin W, Robbins GK, et al. GB virus C (GBV-C) infection in hepatitis C virus (HCV)\/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis. 2006;194:410\u20139.","journal-title":"J Infect Dis"},{"key":"837_CR16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tim.2012.01.004","volume":"20","author":"N Bhattarai","year":"2012","unstructured":"Bhattarai N, Stapleton JT. GB virus C: the good boy virus? Trends Microbiol. 2012;20:124\u201330.","journal-title":"Trends Microbiol"},{"key":"837_CR17","doi-asserted-by":"crossref","first-page":"43293","DOI":"10.18632\/oncotarget.6537","volume":"6","author":"C Wang","year":"2015","unstructured":"Wang C, Timmons CL, Shao Q, Kinlock BL, Turner TM, Iwamoto A, et al. GB virus type C E2 protein inhibits human immunodeficiency virus type 1 gag assembly by downregulating human ADP-ribosylation factor 1. Oncotarget. 2015;6:43293\u2013309.","journal-title":"Oncotarget"},{"key":"837_CR18","doi-asserted-by":"crossref","first-page":"12131","DOI":"10.1128\/JVI.01206-06","volume":"80","author":"JH McLinden","year":"2006","unstructured":"McLinden JH, Kaufman TM, Xiang J, Chang Q, Klinzman D, Engel AM, et al. Characterization of an Immunodominant antigenic site on GB virus C glycoprotein E2 that is involved in cell binding. J Virol. 2006;80:12131\u201340.","journal-title":"J Virol"},{"key":"837_CR19","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1021\/jp900707t","volume":"113","author":"E Herrera","year":"2009","unstructured":"Herrera E, Gomara MJ, Mazzini S, Ragg E, Haro I. Synthetic peptides of hepatitis G virus (GBV-C\/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide. J Phys Chem B. 2009;113:7383\u201391.","journal-title":"J Phys Chem B"},{"key":"837_CR20","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1128\/JVI.02366-10","volume":"85","author":"Y Koedel","year":"2011","unstructured":"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H. Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition. J Virol. 2011;85:7037\u201347.","journal-title":"J Virol"},{"key":"837_CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s007050050268","volume":"143","author":"K Hino","year":"1998","unstructured":"Hino K, Moriya T, Ohno N, Takahashi K, Hoshino H, Ishiyama N, et al. Mother-to-infant transmission occurs more frequently with GB virus C than hepatitis C virus. Arch Virol. 1998;143:65\u201372.","journal-title":"Arch Virol"},{"key":"837_CR22","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1086\/515264","volume":"177","author":"HH Lin","year":"1998","unstructured":"Lin HH, Kao JH, Yeh KY, Liu DP, Chang MH, Chen PJ, et al. Mother-to-infant transmission of GB virus C\/hepatitis G virus: the role of high-titered maternal viremia and mode of delivery. J Infect Dis. 1998;177:1202\u20136.","journal-title":"J Infect Dis"},{"key":"837_CR23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1537-2995.2000.40060725.x","volume":"40","author":"H Ohto","year":"2000","unstructured":"Ohto H, Ujiie N, Sato A, Okamoto H, Mayumi M. Mother-to-infant transmission of GB virus type C\/HGV. Transfusion. 2000;40:725\u201330.","journal-title":"Transfusion"},{"key":"837_CR24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/tmrv.2001.24589","volume":"15","author":"S Kleinman","year":"2001","unstructured":"Kleinman S. Hepatitis G virus biology, epidemiology, and clinical manifestations: implications for blood safety. Transfus Med Rev. 2001;15:201\u201312.","journal-title":"Transfus Med Rev"},{"key":"837_CR25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1590\/S1413-86702005000200001","volume":"9","author":"MT Maidana","year":"2005","unstructured":"Maidana MT, Sabino EC, Kallas EG. GBV-C\/HGV and HIV-1 coinfection. Braz J Infect Dis. 2005;9:122\u20135.","journal-title":"Braz J Infect Dis"},{"key":"837_CR26","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1158\/0008-5472.CAN-14-0209","volume":"74","author":"CM Chang","year":"2014","unstructured":"Chang CM, Stapleton JT, Klinzman D, McLinden JH, Purdue MP, Katki HA, et al. GBV-C infection and risk of NHL among U.S. adults. Cancer Res. 2014;74:5553\u201360.","journal-title":"Cancer Res"},{"key":"837_CR27","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1086\/315283","volume":"181","author":"T Laskus","year":"2000","unstructured":"Laskus T, Radkowski M, Piasek a, Nowicki M, Horban a, Cianciara J, et al. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes\/macrophages and lymphocytes. J Infect Dis. 2000;181:442\u20138.","journal-title":"J Infect Dis"},{"key":"837_CR28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<52::AID-JMV8>3.0.CO;2-L","volume":"61","author":"TJ Tucker","year":"2000","unstructured":"Tucker TJ, Smuts HEM, Eedes C, Knobel GD, Eickhaus P, Robson SC, et al. Evidence that the GBV-C\/hepatitis G virus is primarily a lymphotropic virus. J Med Virol. 2000;61:52\u20138.","journal-title":"J Med Virol"},{"key":"837_CR29","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1099\/vir.0.063016-0","volume":"95","author":"ET Chivero","year":"2014","unstructured":"Chivero ET, Bhattarai N, Rydze RT, Winters MA, Holodniy M, Stapleton JT. Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro. J. Gen. Virol. 2014;95:1307\u201319.","journal-title":"J. Gen. Virol"},{"key":"837_CR30","doi-asserted-by":"crossref","unstructured":"Chivero ET, Stapleton JT. Tropism of human pegivirus (formerly known as GB virus C\/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection. J. Gen. Virol. 2015;96(Pt7):1521\u201332.","DOI":"10.1099\/vir.0.000086"},{"key":"837_CR31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/156652308784049381","volume":"8","author":"A Biffi","year":"2008","unstructured":"Biffi A, Cesani M. Human hematopoietic stem cells in gene therapy: pre-clinical and clinical issues. Curr Gene Ther. 2008;8:135\u201346.","journal-title":"Curr Gene Ther"},{"key":"837_CR32","first-page":"167","volume":"31","author":"N Bhattacharya","year":"2004","unstructured":"Bhattacharya N. Fetal cell\/tissue therapy in adult disease: a new horizon in regenerative medicine. Clin Exp Obstet Gynecol. 2004;31:167\u201373.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"Suppl 1","key":"837_CR33","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.3727\/096368914X684916","volume":"23","author":"JJ Bradstreet","year":"2014","unstructured":"Bradstreet JJ, Sych N, Antonucci N, Klunnik M, Ivankova O, Matyashchuk I, et al. Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study. Cell Transplant. 2014;23(Suppl 1):S105\u201312.","journal-title":"Cell Transplant"},{"key":"837_CR34","first-page":"414","volume":"2","author":"AA Sinelnyk","year":"2015","unstructured":"Sinelnyk AA, Klunnyk MO, Demchuk MP, Sych NS, Ivankova OV, Matiyashchuk IG, Skalozub MV, Novytska AV, Sorochynska KI. Combined therapy using fetal stem cells and a complex of physical exercises in treatment of patients with amyotrophic lateral sclerosis. Integr Mol Med. 2015;2:414\u20139.","journal-title":"Integr Mol Med"},{"key":"837_CR35","first-page":"51","volume":"318","author":"I Madrazo","year":"1988","unstructured":"Madrazo I, Le\u00f3n V, Torres C, Aguilera MC, Varela G, Alvarez F, et al. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson\u2019s disease. N Engl J Med. 1988;318:51.","journal-title":"N Engl J Med"},{"key":"837_CR36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40200-014-0126-x","volume":"14","author":"E Nasli-Esfahani","year":"2015","unstructured":"Nasli-Esfahani E, Ghodsi M, Amini P, Keshtkar AA, Amiri S, Mojahed-Yazdi N, et al. Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up. J Diabetes Metab Disord. 2015;14:33.","journal-title":"J Diabetes Metab Disord"},{"key":"837_CR37","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3727\/096368913X666449","volume":"23","author":"T Piroth","year":"2013","unstructured":"Piroth T, Pauly MC, Schneider C, Wittmer A, Mollers S, Dobrossy M, et al. Transplantation of human fetal tissue for neurodegenerative diseases\u00a0: validation of a new protocol for microbiological analysis and bacterial decontamination. Cell Tranplant. 2013;23:995\u20131007.","journal-title":"Cell Tranplant"},{"key":"837_CR38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3727\/096368916X692735","volume":"26","author":"Y Vitrenko","year":"2017","unstructured":"Vitrenko Y, Kostenko I, Kulebyakina K, Duda A, Klunnyk M, Sorochynska K. Fetal tissues tested for microbial sterility by culture- and PCR-based methods can be safely used in clinics. Cell Transplant. 2017;26:339\u201350.","journal-title":"Cell Transplant"},{"key":"837_CR39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000317290","volume":"53","author":"R Abu Odeh","year":"2010","unstructured":"Abu Odeh R, Yasin S, Nasrallah G, Babi Y. Rates of infection and Phylogenetic analysis of GB virus-C among Kuwaiti and Jordanian blood donors. Intervirology. 2010;53:402\u20137.","journal-title":"Intervirology"},{"key":"837_CR40","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2011","unstructured":"Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731\u20139.","journal-title":"Mol Biol Evol"},{"key":"837_CR41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/jmv.23893","volume":"86","author":"CK Lee","year":"2014","unstructured":"Lee CK, Tang JW-T, Chiu L, Loh TP, Olszyna D, Chew N, et al. Epidemiology of GB virus type C among patients infected with HIV in Singapore. J Med Virol. 2014;86:737\u201344.","journal-title":"J Med Virol"},{"key":"837_CR42","doi-asserted-by":"crossref","first-page":"W35","DOI":"10.1093\/nar\/gkn211","volume":"36","author":"M Garcia-Boronat","year":"2008","unstructured":"Garcia-Boronat M, Diez-Rivero CM, Reinherz EL, Reche PA. PVS: a web server for protein sequence variability analysis tuned to facilitate conserved epitope discovery. Nucleic Acids Res. 2008;36:W35\u201341.","journal-title":"Nucleic Acids Res"},{"key":"837_CR43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/bioinformatics\/15.5.413","volume":"15","author":"Y Guermeur","year":"1999","unstructured":"Guermeur Y, Geourjon C, Gallinari P, Del\u00e9age G. Improved performance in protein secondary structure prediction by inhomogeneous score combination. Bioinformatics. 1999;15:413\u201321.","journal-title":"Bioinformatics"},{"key":"837_CR44","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1006\/jmbi.1999.3310","volume":"294","author":"N Blom","year":"1999","unstructured":"Blom N, Gammeltoft S, Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol. 1999;294:1351\u201362.","journal-title":"J Mol Biol"},{"key":"837_CR45","doi-asserted-by":"crossref","first-page":"e15342","DOI":"10.5812\/hepatmon.15342","volume":"13","author":"MM Ranjbar","year":"2013","unstructured":"Ranjbar MM, Ghorban K, Alavian SM, Keyvani H, dadmanesh M, Roayaei Ardakany A, et al. GB virus C\/hepatitis G virus envelope glycoprotein E2: computational molecular features and Immunoinformatics study. Hepat Mon. 2013;13:e15342.","journal-title":"Hepat Mon"},{"key":"837_CR46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.abb.2005.06.027","volume":"442","author":"C Larios","year":"2005","unstructured":"Larios C, Casas J, Alsina MA, Mestres C, G\u00f3mara MJ, Haro I. Characterization of a putative fusogenic sequence in the E2 hepatitis G virus protein. Arch Biochem Biophys. 2005;442:149\u201359.","journal-title":"Arch Biochem Biophys"},{"key":"837_CR47","doi-asserted-by":"crossref","first-page":"8929","DOI":"10.3748\/wjg.v19.i47.8929","volume":"19","author":"J Hundt","year":"2013","unstructured":"Hundt J, Li Z, Liu Q. Post-translational modifications of hepatitis C viral proteins and their biological significance. World J Gastroenterol. 2013;19:8929.","journal-title":"World J Gastroenterol"},{"key":"837_CR48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejogrb.2009.02.043","volume":"144","author":"D Paternoster","year":"2009","unstructured":"Paternoster D, Serena A, Santin M, Marchiori S, Surico N, Amoruso E, et al. GB virus C infection in pregnancy: maternal and perinatal importance of the infection. Eur J Obstet Gynecol Reprod Biol. 2009;144:115\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"837_CR49","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.3748\/wjg.14.4725","volume":"14","author":"VI Reshetnyak","year":"2008","unstructured":"Reshetnyak VI, Karlovich TI, Ilchenko LU. Hepatitis G virus. World J Gastroenterol. 2008;14:4725\u201334.","journal-title":"World J Gastroenterol"},{"key":"837_CR50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1096-9071(199807)55:3<203::AID-JMV4>3.0.CO;2-5","volume":"55","author":"MF Scallan","year":"1998","unstructured":"Scallan MF, Clutterbuck D, Jarvis LM, Scott GR, Simmonds P. Sexual transmission of GB virus C\/hepatitis G virus. J Med Virol. 1998;55:203\u20138.","journal-title":"J Med Virol"},{"key":"837_CR51","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.4049\/jimmunol.1300589","volume":"190","author":"N Bhattarai","year":"2013","unstructured":"Bhattarai N, McLinden JH, Xiang J, Landay AL, Chivero ET, Stapleton JT. GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling. J Immunol. 2013;190:6351\u20139.","journal-title":"J Immunol"},{"key":"837_CR52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1086\/514245","volume":"177","author":"DL Thomas","year":"1998","unstructured":"Thomas DL, Vlahov D, Alter HJ, Hunt JC, Marshall R, Astemborski J, et al. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis. 1998;177:539\u201342.","journal-title":"J Infect Dis"},{"key":"837_CR53","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molmed.2016.02.002","volume":"22","author":"C Booth","year":"2016","unstructured":"Booth C, Gaspar HB, Thrasher AJ. Treating immunodeficiency through HSC gene therapy. Trends Mol Med. 2016;22:317\u201327.","journal-title":"Trends Mol Med"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-017-0837-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T20:19:46Z","timestamp":1570047586000},"score":1,"resource":{"primary":{"URL":"http:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-017-0837-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,31]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1186\/s12985-017-0837-y","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,31]]},"article-number":"167"}}